Below are few examples of how we have shown the utility of the software in a lymphoblastoid cell line, Sanger validation of an ER+ tumor sequenced at Mayo, TCGA ER+ breast tumors and single-cell RNA-Seq data from a breast cancer cell line (Supplementary Methods). Here, ESR1 is linked to breast carcinoma.